817 filings
Page 10 of 41
8-K
08tm4
17 Jul 19
Seelos Therapeutics Announces Investigational New Drug Application Submission for SLS-005
9:07am
8-K
fhgexs5
27 Jun 19
Validated, Pre-Clinical Success Shown in Modifying the Regulation of the SNCA Gene Which Encodes Alpha-Synuclein Expression
7:24am
8-K
tceptq4by z1020hpe9
17 Jun 19
Entry into a Material Definitive Agreement
9:55pm
424B5
mdamy
17 Jun 19
Prospectus supplement for primary offering
9:55pm
8-K
0w3rvx1lgz t26qas
21 May 19
Seelos Therapeutics Reports Q1 2019 Pipeline Update
2:40pm
NT 10-Q
4a3m9mvdtux0dm5x
15 May 19
Notice of late quarterly filing
5:00pm
8-K
4qr 9ksrz
13 May 19
Departure of Directors or Certain Officers
5:02pm
8-K
k87l3gz95ai ziwrysi2
8 Apr 19
Changes in Registrant's Certifying Accountant
4:15pm
8-K
n36p9u
26 Mar 19
Departure of Directors or Certain Officers
4:55pm
424B3
dlcm6 vck
8 Mar 19
Prospectus supplement
6:45am
8-K
ldsfd61
8 Mar 19
Entry into a Material Definitive Agreement
6:39am
8-K/A
px2vcd877t iisuc
1 Mar 19
Departure of Directors or Certain Officers
4:19pm
S-8
lyyyl lf8
25 Feb 19
Registration of securities for employees
4:43pm
8-K
hgeae498rs7l6w
19 Feb 19
Seelos Therapeutics Completes Acquisition of Trehalose from Bioblast Pharma
8:00am
424B3
06aqcr8m
13 Feb 19
Prospectus supplement
4:45pm
424B3
7qonzhkkt1b0pnjn39
13 Feb 19
Prospectus supplement
4:44pm
EFFECT
bwfj3txc97vbxashg
13 Feb 19
Notice of effectiveness
12:00am